IL17A and Alzheimer disease: The secreted IL-1β further amplifies the neuroinflammation in AD by inducing other cytokines and chemokines, such as IL-6 and IL-17, leading to a cycle that exacerbates neuronal damage, cell death, and neurodegeneration [23,25].